Istradefylline Impurities and its Related Products



Displaying 9 results of Istradefylline Impurities

Istradefylline impurities are unwanted substances that may be present in pharmaceutical formulations of istradefylline, a medication used to treat Parkinson's disease. These impurities can negatively affect the safety, efficacy, and stability of the drug. Therefore, it is important to identify and quantify these impurities to ensure the quality and purity of the medication. Various analytical techniques, such as chromatography and spectroscopy, are used to detect and quantify istradefylline impurities.
COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
(Z)-Istradefylline Impurities CS-O-14578 Not Available Enquire
2-Desmethyl Istradefylline Impurities CS-O-14577 155272-04-1 Enquire
3,4-Dimethoxycinnamamide Impurities CS-ED-41673 14773-40-1 Enquire
4-Desmethyl Istradefylline Impurities CS-T-16260 160434-48-0 Enquire
Istradefylline Dimer Impurity Impurities CS-O-14579 702697-27-6 Enquire
Istradefylline Impurity 2 Impurities CS-P-01056 606080-73-3 Enquire
Istradefylline Impurity 7 Impurities CS-O-46821 1453190-01-6 Enquire
Istradefylline-d3 Impurities CS-O-44782 Not Available Enquire
Methyl ethylcarbamate Impurities CS-ED-41674 6135-31-5 Enquire